Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jalving

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cancer Treatment Reviews|August 12, 2018
Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer - ESMO-MCBS scoresK E Broekman, M Jalving, H van Tinteren, et al.
Immuno-Oncology Technology|June 27, 2022
Driving innovation for rare skin cancers: utilizing common tumours and machine learning to predict immune checkpoint inhibitor responseJ S Hooiveld-Noeken, R S N Fehrmann, E G E de Vries, et al.
Critical Reviews in Oncology/Hematology|July 17, 2020
Rational use of <sup>18</sup>F-FDG PET/CT in patients with advanced cutaneous melanoma: A systematic reviewC Bisschop, E C de Heer, A H Brouwers, et al.
Alimentary Pharmacology & Therapeutics|February 16, 2005
Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancerM Jalving, J J Koornstra, S De Jong, et al.
Alimentary Pharmacology & Therapeutics|October 25, 2006
Increased risk of fundic gland polyps during long-term proton pump inhibitor therapyM Jalving, J J Koornstra, J Wesseling, et al.
ESMO Open|August 9, 2021
Clinical benefit of systemic therapies for recurrent ovarian cancer-ESMO-MCBS scoresK E Broekman, M van Kruchten, H van Tinteren, et al.
Cancer Treatment Reviews|March 1, 2015
Cancer-drug induced insulin resistance: innocent bystander or unusual suspectG Ariaans, S de Jong, J A Gietema, et al.
Cancer Treatment Reviews|July 19, 2024
Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing actJ F Tiersma, B Evers, B M Bakker, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|August 30, 2007
Independent induction of caspase-8 and cFLIP expression during colorectal carcinogenesis in sporadic and HNPCC adenomas and carcinomasD M Heijink, J H Kleibeuker, M Jalving, et al.
Psycho-Oncology|December 17, 2017
Predictors of adherence to exercise interventions during and after cancer treatment: A systematic reviewH L Ormel, G G F van der Schoot, W J Sluiter, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancer Treatment Reviews|August 12, 2018
Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer - ESMO-MCBS scoresK E Broekman, M Jalving, H van Tinteren, et al.
Immuno-Oncology Technology|June 27, 2022
Driving innovation for rare skin cancers: utilizing common tumours and machine learning to predict immune checkpoint inhibitor responseJ S Hooiveld-Noeken, R S N Fehrmann, E G E de Vries, et al.
Critical Reviews in Oncology/Hematology|July 17, 2020
Rational use of <sup>18</sup>F-FDG PET/CT in patients with advanced cutaneous melanoma: A systematic reviewC Bisschop, E C de Heer, A H Brouwers, et al.
Alimentary Pharmacology & Therapeutics|February 16, 2005
Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancerM Jalving, J J Koornstra, S De Jong, et al.
Alimentary Pharmacology & Therapeutics|October 25, 2006
Increased risk of fundic gland polyps during long-term proton pump inhibitor therapyM Jalving, J J Koornstra, J Wesseling, et al.
ESMO Open|August 9, 2021
Clinical benefit of systemic therapies for recurrent ovarian cancer-ESMO-MCBS scoresK E Broekman, M van Kruchten, H van Tinteren, et al.
Cancer Treatment Reviews|March 1, 2015
Cancer-drug induced insulin resistance: innocent bystander or unusual suspectG Ariaans, S de Jong, J A Gietema, et al.
Cancer Treatment Reviews|July 19, 2024
Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing actJ F Tiersma, B Evers, B M Bakker, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|August 30, 2007
Independent induction of caspase-8 and cFLIP expression during colorectal carcinogenesis in sporadic and HNPCC adenomas and carcinomasD M Heijink, J H Kleibeuker, M Jalving, et al.
Psycho-Oncology|December 17, 2017
Predictors of adherence to exercise interventions during and after cancer treatment: A systematic reviewH L Ormel, G G F van der Schoot, W J Sluiter, et al.
Pageof 3